Skip to content

To Measure Pain Perception Following De-Epithelized Free Gingival Graft Harvesting

A Randomized Controlled Trial to Measure Pain Perception Following De-Epithelized Free Gingival Graft Harvesting

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03895476
Enrollment
72
Registered
2019-03-29
Start date
2020-06-08
Completion date
2023-02-27
Last updated
2024-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival Recession, Palate; Wound

Brief summary

This randomized clinical comparative study will evaluate the postoperative pain following the FGG graft harvest procedure technique covered by four different methods for coverage of the palatal donor site.

Detailed description

This study will compare the application of : * hemostatic collagen sponge * collagen sponge sealed with abio-adhesive material * Platelet rich fibrin * physical barrier (stent) on the palatal donor sites with the purpose of which one of these will result in least postoperative pain after epithelialized gingival graft (EGG) harvesting.

Interventions

DIAGNOSTIC_TESTpalatal wound will be cover with collagen and sutures

after harvesting the graft from the palate, a collagen sponge will be sutured to cover the harvested site

DIAGNOSTIC_TESTpalatal wound covered with platelet rich fibrin

after harvesting the graft from the palate the platelet rich fibrin will be sutured to covered the harvested site

DIAGNOSTIC_TESTpalatal wound covered with a collagen sponge and cyanoacrylate

after harvesting the graft from the palate a collagen sponge will be sealed with cyanoacrylate in position

DIAGNOSTIC_TESTpalatal wound covered with a stent

after harvesting the graft from the palate a stent that will be prepared for the patient, will be placed on to cover the wound

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* English speaking * At least 18 years old- 70 years old * Must be a patient of the UAB Dental School * Able to read and understand informed consent document * Patients needing soft tissue graft with teeth that have miller class I or II recession (\>=2mm) on the facial aspects * Presence of periodontally healthy teeth at the recipient site. * Ability of the participants to maintain good oral hygiene * Patient not pregnant or breastfeeding * Not taking medications known to cause gingival enlargement

Exclusion criteria

* Non-English speaking * Less than 18 years old, older than 70 years old * Smokers/tobacco users * Patients with systemic pathologies or conditions contraindicating oral surgical procedures or adversely affecting wound healing * Patients that have severe gingival recession (Miller class III and IV) or \< 2 mm. * Presence of periodontal disease at the recipient site. * Poor oral hygiene * Patient pregnant or breastfeeding * Taking medications known to cause gingival enlargement

Design outcomes

Primary

MeasureTime frameDescription
Pain Assessment (0=No Pain to 10=Worst)day 14To assess the pain outcomes using the visual analog scale from 0=No pain to 10=worst, excrutiating pain. Assessed daily from days 1 to 14, Day 14 reported.
Bleeding Assessmentday 14To assessed the bleeding outcomes using the visual analog scale (VAS) from 0=No bruising/bleeding to 10=severe bruising/bleeding. Assessed daily from days 1 to 14, Day 14 reported.

Secondary

MeasureTime frameDescription
Activity Toleranceday 14To assess the effects on daily activities using the visual analog scale from 0=No Limitation to 10= Bedrest required. Assessed daily from days 1 to 14, Day 14 reported.
Amount of Swellingday 14To assessed the swelling outcomes using the visual scale (VAS) from 0=No swelling to 10=severe swelling. Assessed daily from days 1 to 14, Day 14 reported.
The Need for Painkillerday 14To assess the needs for the painkiller using the visual analog scale (VAS). (0 = No painkiller needed to 10 = Needed painkiller). Assessed daily from days 1 to 14, Day 14 reported.

Countries

United States

Participant flow

Participants by arm

ArmCount
Collagen Plug With Sutures
Palatal wound will be protected with collagen plug and sutures. palatal wound will be cover with collagen and sutures: after harvesting the graft from the palate, a collagen sponge will be sutured to cover the harvested site
18
Platelet Rich Fibrin (PRF)
palatal wound will be protected with Platelet rich Fibrin palatal wound covered with platelet rich fibrin: after harvesting the graft from the palate the platelet rich fibrin will be sutured to covered the harvested site
18
Collagen Plug With Cyanoacrylate (CPC)
Palatal wound will consist of collagen protection with the additional layer of cyanoacrylate surgical glue. palatal wound covered with a collagen sponge and cyanoacrylate: after harvesting the graft from the palate a collagen sponge will be sealed with cyanoacrylate in position
18
Palatal Stent
Palatal wound will be protected with palatal stent. palatal wound covered with a stent: after harvesting the graft from the palate a stent that will be prepared for the patient, will be placed on to cover the wound
18
Total72

Baseline characteristics

CharacteristicPlatelet Rich Fibrin (PRF)Collagen Plug With Cyanoacrylate (CPC)Collagen Plug With SuturesPalatal StentTotal
Age, Categorical
<=18 years
0 Participants0 Participants1 Participants0 Participants1 Participants
Age, Categorical
>=65 years
12 Participants3 Participants7 Participants6 Participants28 Participants
Age, Categorical
Between 18 and 65 years
6 Participants15 Participants10 Participants12 Participants43 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants2 Participants2 Participants
Race (NIH/OMB)
Black or African American
1 Participants2 Participants1 Participants1 Participants5 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
17 Participants16 Participants17 Participants15 Participants65 Participants
Sex: Female, Male
Female
14 Participants10 Participants11 Participants10 Participants45 Participants
Sex: Female, Male
Male
4 Participants8 Participants7 Participants8 Participants27 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 180 / 180 / 180 / 18
other
Total, other adverse events
0 / 180 / 180 / 180 / 18
serious
Total, serious adverse events
0 / 180 / 180 / 180 / 18

Outcome results

Primary

Bleeding Assessment

To assessed the bleeding outcomes using the visual analog scale (VAS) from 0=No bruising/bleeding to 10=severe bruising/bleeding. Assessed daily from days 1 to 14, Day 14 reported.

Time frame: day 14

ArmMeasureValue (MEAN)Dispersion
Collagen Plug With SuturesBleeding Assessment1 score on a scaleStandard Deviation 1.9
Platelet Rich Fibrin (PRF)Bleeding Assessment0.6 score on a scaleStandard Deviation 1.4
Collagen Plug With Cyanoacrylate (CPC)Bleeding Assessment0.9 score on a scaleStandard Deviation 1.9
Palatal StentBleeding Assessment0.7 score on a scaleStandard Deviation 1.6
Primary

Pain Assessment (0=No Pain to 10=Worst)

To assess the pain outcomes using the visual analog scale from 0=No pain to 10=worst, excrutiating pain. Assessed daily from days 1 to 14, Day 14 reported.

Time frame: day 14

ArmMeasureValue (MEAN)Dispersion
Collagen Plug With SuturesPain Assessment (0=No Pain to 10=Worst)4.2 score on a scaleStandard Deviation 2.4
Platelet Rich Fibrin (PRF)Pain Assessment (0=No Pain to 10=Worst)1.9 score on a scaleStandard Deviation 2.1
Collagen Plug With Cyanoacrylate (CPC)Pain Assessment (0=No Pain to 10=Worst)2.2 score on a scaleStandard Deviation 2.5
Palatal StentPain Assessment (0=No Pain to 10=Worst)1 score on a scaleStandard Deviation 1.4
Secondary

Activity Tolerance

To assess the effects on daily activities using the visual analog scale from 0=No Limitation to 10= Bedrest required. Assessed daily from days 1 to 14, Day 14 reported.

Time frame: day 14

ArmMeasureValue (MEAN)Dispersion
Collagen Plug With SuturesActivity Tolerance2.4 score on a scaleStandard Deviation 2.4
Platelet Rich Fibrin (PRF)Activity Tolerance1.5 score on a scaleStandard Deviation 2.1
Collagen Plug With Cyanoacrylate (CPC)Activity Tolerance1.8 score on a scaleStandard Deviation 2.4
Palatal StentActivity Tolerance1.3 score on a scaleStandard Deviation 1.8
Secondary

Amount of Swelling

To assessed the swelling outcomes using the visual scale (VAS) from 0=No swelling to 10=severe swelling. Assessed daily from days 1 to 14, Day 14 reported.

Time frame: day 14

ArmMeasureValue (MEAN)Dispersion
Collagen Plug With SuturesAmount of Swelling2.2 score on a scaleStandard Deviation 2.4
Platelet Rich Fibrin (PRF)Amount of Swelling1.3 score on a scaleStandard Deviation 1.9
Collagen Plug With Cyanoacrylate (CPC)Amount of Swelling1.4 score on a scaleStandard Deviation 2
Palatal StentAmount of Swelling1.3 score on a scaleStandard Deviation 2
Secondary

The Need for Painkiller

To assess the needs for the painkiller using the visual analog scale (VAS). (0 = No painkiller needed to 10 = Needed painkiller). Assessed daily from days 1 to 14, Day 14 reported.

Time frame: day 14

ArmMeasureValue (MEAN)Dispersion
Collagen Plug With SuturesThe Need for Painkiller2.1 score on a scaleStandard Deviation 2.5
Platelet Rich Fibrin (PRF)The Need for Painkiller2 score on a scaleStandard Deviation 2.6
Collagen Plug With Cyanoacrylate (CPC)The Need for Painkiller2.2 score on a scaleStandard Deviation 2.8
Palatal StentThe Need for Painkiller1.5 score on a scaleStandard Deviation 1.8

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026